Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective

Bibliographic Details
Main Authors: Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
Format: Article
Language:English
Published: Adis, Springer Healthcare 2022-12-01
Series:Rheumatology and Therapy
Subjects:
Psoriatic arthritis
Sequencing
Treatment
Outcomes
b/tsDMARDs
Online Access:https://doi.org/10.1007/s40744-022-00514-0

Similar Items

Similar Items